kalkinemedia17d
AEON Biopharma (NYSE: AEON) Announces 1-for-72 Reverse Stock Split
Highlights,AEON Biopharma implements 1-for-72 reverse stock split to maintain NYSE compliance.,New split ratio approved by stockholders at February 24 meeting.,Fractional shares rounded up to the ...
Stocktwits on MSN11d
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
AIM ImmunoTech surged in retail discussions after announcing the first new subject was dosed in Phase 2 of its Phase 1b/2 ...
TMCnet17d
AEON Biopharma, Inc. Announces Reverse Stock Split
AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced that the Company’s Board of ...
AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference
AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...
Nasdaq17d
AEON Biopharma To Implement 1-for-72 Reverse Stock Split For Compliance With NYSE Rules
(RTTNews) - AEON Biopharma, Inc. (AEON), a clinical-stage biopharmaceutical company, announced that its Board of Directors has approved a 1-for-72 reverse stock split of its common stock ...